Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» semaglutide
semaglutide
These 2 European Pharmas Grabbed Upgrades Ahead Of 2018 News
Investors Business Daily
Tue, 01/2/18 - 11:42 am
Europe
AstraZeneca
Lynparza
ovarian cancer
Novo Nordisk
diabetes
semaglutide
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
Endpoints
Sun, 12/17/17 - 11:47 am
drug launches
Bictegravir/F/TAF
Gilead Sciences
semaglutide
Novo Nordisk
epacadostat
Incyte
Rova-T
AbbVie
ozanimod
Celgene
apalutamide
JNJ
Elagolix
AVXS-101
AveXis
lanadelumab
Shire
Epidiolex
GW Pharma
Novo gains FDA OK for semaglutide
BioPharma Dive
Wed, 12/6/17 - 11:48 pm
Novo Nordisk
semaglutide
FDA
Ozempic
type 2 diabetes
Building on impressive data, Novo Nordisk maps big PhIII obesity program for blockbuster hopeful semaglutide
Endpoints
Tue, 11/21/17 - 11:28 am
Novo Nordisk
obesity
semaglutide
With FDA panel backing, Novo Nordisk prepares for semaglutide's potential launch
Fierce Biotech
Thu, 10/19/17 - 12:00 pm
FDA
Novo Nordisk
semaglutide
diabetes
Novo's experimental diabetes drug likely to compete with Trulicity
Medical Marketing and Media
Tue, 10/17/17 - 08:29 pm
Novo Nordisk
diabetes
Trulicity
semaglutide
FDA gives Novo Nordisk top grades for its diabetes drug semaglutide, but retinopathy remains key
Endpoints
Mon, 10/16/17 - 09:42 am
FDA
Novo Nordisk
diabetes
semaglutide
diabetic retinopathy
Diabetes drugs must prove their value to payers, analysts say
Medical Marketing and Media
Tue, 08/22/17 - 06:48 pm
diabetes
payers
Novo Nordisk
semaglutide
Eli Lilly
Trulicity
Novo focuses on new obesity therapy Semaglutide
GoInPharma
Tue, 08/15/17 - 09:31 am
Novo Nordisk
obesity
semaglutide
Can Novo’s blockbuster push on obesity drug semaglutide succeed where others failed?
Endpoints
Thu, 08/10/17 - 11:36 am
Novo Nordisk
semaglutide
obesity
Puma's FDA Decider And Semaglutide's Head-To-Head Battle
Seeking Alpha
Mon, 07/10/17 - 11:09 am
Puma Biotechnology
FDA
Novo Nordisk
Nerlynx
neratinib
semaglutide
Novo Nordisk says obesity drug helps up to 13.8 percent weight loss in phase 2 trial
Reuters
Mon, 06/26/17 - 05:15 pm
Novo Nordisk
obesity
semaglutide
3 Tremendously Promising Diabetes Drugs Potentially on the Way
Motley Fool
Sun, 03/26/17 - 12:02 pm
diabetes
ertugliflozin
Merck
Pfizer
sotagliflozin
Sanofi
Lexicon Pharmaceuticals
semaglutide
Novo Nordisk
Novo Nordisk's diabetes drug semaglutide cuts heart risk by 26 percent
Yahoo/Reuters
Sat, 09/17/16 - 01:16 pm
Novo Nordisk
semaglutide
diabetes
Novo Nordisk notches another phase 3 success for GLP-1 drug
BioPharma Dive
Fri, 02/26/16 - 10:18 am
Novo Nordisk
diabetes
GLP-1 agonist
semaglutide
Novo Nordisk's weekly diabetes drug goes 5-for-5 in Phase III
Fierce Biotech
Thu, 02/25/16 - 09:58 am
diabetes
Novo Nordisk
semaglutide
Novo Nordisk's First Diabetes Pill Could Be A $10-20 Billion Super-Blockbuster
Seeking Alpha
Fri, 11/27/15 - 11:59 am
Novo Nordisk
diabetes
semaglutide
GLP-1 agonist
Novo Nordisk's PIONEER Trial Will Establish A New Frontier In Oral Anti-Diabetics
Seeking Alpha
Sat, 11/21/15 - 12:28 pm
Novo Nordisk
diabetes
semaglutide
Novo's weekly diabetes drug clears another Phase III hurdle
Fierce Biotech
Fri, 09/25/15 - 08:45 pm
Novo Nordisk
diabetes
semaglutide
Bydureon
AstraZeneca
Intarcia vs. Novo: Which has the most appealing diabetes PhIII program?
Fierce Pharma
Fri, 08/28/15 - 05:44 pm
Novo Nordisk
Intarcia
diabetes
ITCA-650
Merck
Januvia
semaglutide
Pages
« first
‹ previous
1
2
3
4
next ›
last »